The AudibleHealth Dx Diagnostic Software as a Medical Device (SaMD) platform is designed to diagnose illness by analyzing the sound of a person’s Forced Cough Vocalization (FCV) using artificial intelligence.

The cloud-based diagnostic platform is highly scalable and secure, and uses a mobile app as the user interface. The device is designed so that users cough 8 to 10 times into the app, and receive the diagnostic results in about 2 minutes. This fully digital diagnostic approach is designed to allow for fast and easy diagnostic testing with no swabs, no lines, no waste, no expiration dates, and no waiting.

Learn more about the AudibleHealth Dx SaMD submission to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) >

Learn more about RAIsonance’s BARDA contract award for the continued development of AudibleHealth Dx >

Learn more AudibleHealth.ai >

Audible Health Dx

AudibleHealth Dx is an investigational diagnostic SaMD platform, designed to diagnose COVID-19, TB, and Influenza using only the sound of a person’s cough via a mobile app.

AudibleHealth Dx is currently under review by the FDA and Health Canada.

A new era in diagnostic testing.

Our AI-powered diagnostic testing platform is designed to make testing faster, more convenient, non-invasive, and effortlessly scalable.

Let’s discuss how we can help you >